The ZIKV/DENV DUO ELISA was developed based upon the hypothesis that confirmation and discrimination of recent infections is more likely to occur by the detection of IgM, an isotype that is detectable early in infection and then wanes over time, than by the detection of neutralizing antibodies that are more likely to be reflective of both recent and remote infections. This evidence concerns the gene CD40LG and infection.